Characteristics of total mentees (N = 35) who participated in program
. | Median (IQR) or n (%) . |
---|---|
Age | 32 (30-33) |
Sex assigned at birth | |
Female | 28 (80%) |
Male | 7 (20%) |
Gender identity | |
Female | 28 (80%) |
Male | 7 (20%) |
Race/ethnicity | |
White | 16 (46%) |
Asian | 12 (34%) |
Black | 2 (6%) |
Arab | 1 (3%) |
White and Native American | 1 (3%) |
Hispanic | 3 (8%) |
Type of medical degree | |
MD or MBBS | 30 (86%) |
DO | 5 (14%) |
Location of medical degree | |
United States | 25 (71%) |
International medical graduate | 10 (29%) |
Type of H/O fellowship | |
Adult | 12 (34%) |
Pediatric | 23 (66%) |
Year of training at time of application | |
First-year fellow | 10 (28%) |
Second-year fellow | 16 (46%) |
Third-year fellow | 7 (20%) |
Third-year resident∗ | 2 (6%) |
Year of training after start of program† | |
First-year fellow | 2 (6%) |
Second-year fellow | 10 (28%) |
Third-year fellow | 17 (49%) |
>Third-year fellow | 6 (17%) |
Location of current US training program | |
West | 5 (14%) |
Southwest | 2 (6%) |
Midwest | 11 (31%) |
Southeast | 7 (20%) |
Northeast | 10 (29%) |
Previous CH mentorship before program | 24 (69%) |
Previous research experience in CH before program‡ | 30 (86%) |
Participated in a formal hematology-focused research program before this program§ | 9 (26%) |
Total publications|| before program | 3 (1-6) |
CH publications§ before program | 1 (0-2) |
Total poster/oral presentations before program | 6 (3-10) |
CH poster/oral presentations before program | 2 (1-3) |
Medical education or quality improvement activity related to CH before program | 22 (63%) |
Member of a H/O professional society | 28 (80%) |
. | Median (IQR) or n (%) . |
---|---|
Age | 32 (30-33) |
Sex assigned at birth | |
Female | 28 (80%) |
Male | 7 (20%) |
Gender identity | |
Female | 28 (80%) |
Male | 7 (20%) |
Race/ethnicity | |
White | 16 (46%) |
Asian | 12 (34%) |
Black | 2 (6%) |
Arab | 1 (3%) |
White and Native American | 1 (3%) |
Hispanic | 3 (8%) |
Type of medical degree | |
MD or MBBS | 30 (86%) |
DO | 5 (14%) |
Location of medical degree | |
United States | 25 (71%) |
International medical graduate | 10 (29%) |
Type of H/O fellowship | |
Adult | 12 (34%) |
Pediatric | 23 (66%) |
Year of training at time of application | |
First-year fellow | 10 (28%) |
Second-year fellow | 16 (46%) |
Third-year fellow | 7 (20%) |
Third-year resident∗ | 2 (6%) |
Year of training after start of program† | |
First-year fellow | 2 (6%) |
Second-year fellow | 10 (28%) |
Third-year fellow | 17 (49%) |
>Third-year fellow | 6 (17%) |
Location of current US training program | |
West | 5 (14%) |
Southwest | 2 (6%) |
Midwest | 11 (31%) |
Southeast | 7 (20%) |
Northeast | 10 (29%) |
Previous CH mentorship before program | 24 (69%) |
Previous research experience in CH before program‡ | 30 (86%) |
Participated in a formal hematology-focused research program before this program§ | 9 (26%) |
Total publications|| before program | 3 (1-6) |
CH publications§ before program | 1 (0-2) |
Total poster/oral presentations before program | 6 (3-10) |
CH poster/oral presentations before program | 2 (1-3) |
Medical education or quality improvement activity related to CH before program | 22 (63%) |
Member of a H/O professional society | 28 (80%) |
DO, Doctor of Osteopathic Medicine; MBBS, Bachelor of Medicine and Bachelor of Surgery; MD, Doctor of Medicine.
Pediatrics residents.
Obtained from survey distributed 6 months into program (N = 35).
Based on experiences listed as research or as original publication or presentation (excluding case reports) in curriculum vitae.
Includes ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS), HTRS Trainee Workshop, and HTRS Hematology Fellows Consortium.
Includes in-preparation, submitted, under review, accepted, and published manuscripts.